LLY

768.15

+2.94%↑

JNJ

176.55

-0.3%↓

ABBV

216.89

+0.98%↑

UNH

341.7

-2.13%↓

AZN

77.95

+0.22%↑

LLY

768.15

+2.94%↑

JNJ

176.55

-0.3%↓

ABBV

216.89

+0.98%↑

UNH

341.7

-2.13%↓

AZN

77.95

+0.22%↑

LLY

768.15

+2.94%↑

JNJ

176.55

-0.3%↓

ABBV

216.89

+0.98%↑

UNH

341.7

-2.13%↓

AZN

77.95

+0.22%↑

LLY

768.15

+2.94%↑

JNJ

176.55

-0.3%↓

ABBV

216.89

+0.98%↑

UNH

341.7

-2.13%↓

AZN

77.95

+0.22%↑

LLY

768.15

+2.94%↑

JNJ

176.55

-0.3%↓

ABBV

216.89

+0.98%↑

UNH

341.7

-2.13%↓

AZN

77.95

+0.22%↑

Search

Dynavax Technologies Corp

Deschisă

SectorSănătate

9.62 3.55

Rezumat

Modificarea prețului

24h

Curent

Minim

9.2

Maxim

9.63

Indicatori cheie

By Trading Economics

Venit

115M

19M

Vânzări

27M

95M

P/E

Medie Sector

58.75

35.664

Marjă de profit

19.615

Angajați

405

EBITDA

119M

25M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+140.91% upside

Dividende

By Dow Jones

Următoarele câștiguri

6 nov. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-201M

1.1B

Deschiderea anterioară

6.07

Închiderea anterioară

9.62

Sentimentul știrilor

By Acuity

32%

68%

106 / 371 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

Dynavax Technologies Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

15 sept. 2025, 22:39 UTC

Achiziții, Fuziuni, Preluări

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15 sept. 2025, 16:43 UTC

Principalele dinamici ale pieței

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15 sept. 2025, 16:42 UTC

Principalele dinamici ale pieței

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15 sept. 2025, 16:35 UTC

Principalele dinamici ale pieței

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15 sept. 2025, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 sept. 2025, 23:46 UTC

Market Talk

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15 sept. 2025, 23:34 UTC

Market Talk

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15 sept. 2025, 22:48 UTC

Market Talk

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15 sept. 2025, 22:12 UTC

Achiziții, Fuziuni, Preluări

CSL Expects Commercial Launch in 2029

15 sept. 2025, 22:12 UTC

Achiziții, Fuziuni, Preluări

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15 sept. 2025, 22:11 UTC

Achiziții, Fuziuni, Preluări

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15 sept. 2025, 22:11 UTC

Achiziții, Fuziuni, Preluări

CSL to Have Right to Exercise Option Based on Phase 3 Data

15 sept. 2025, 22:10 UTC

Achiziții, Fuziuni, Preluări

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15 sept. 2025, 21:16 UTC

Achiziții, Fuziuni, Preluări

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15 sept. 2025, 21:16 UTC

Achiziții, Fuziuni, Preluări

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15 sept. 2025, 21:15 UTC

Achiziții, Fuziuni, Preluări

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15 sept. 2025, 21:14 UTC

Achiziții, Fuziuni, Preluări

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15 sept. 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15 sept. 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

15 sept. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15 sept. 2025, 19:29 UTC

Market Talk

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15 sept. 2025, 19:14 UTC

Market Talk

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15 sept. 2025, 18:16 UTC

Market Talk

Gold Powers to New High -- Market Talk

15 sept. 2025, 18:05 UTC

Market Talk

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15 sept. 2025, 17:50 UTC

Achiziții, Fuziuni, Preluări

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15 sept. 2025, 17:10 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 sept. 2025, 17:10 UTC

Market Talk

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15 sept. 2025, 16:52 UTC

Market Talk

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15 sept. 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

15 sept. 2025, 16:20 UTC

Market Talk
Câștiguri

Auto & Transport Roundup: Market Talk

Comparație

Modificare preț

Dynavax Technologies Corp Așteptări

Obiectiv de preț

By TipRanks

140.91% sus

Prognoză pe 12 luni

Medie 22.67 USD  140.91%

Maxim 32 USD

Minim 11 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruDynavax Technologies Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

4 ratings

3

Cumpărare

0

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

9.62 / 10.9Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Very Strong Bearish Evidence

Termen lung

Strong Bearish Evidence

Sentiment

By Acuity

106 / 371 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Dynavax Technologies Corp

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.
help-icon Live chat